1998
DOI: 10.1097/00002030-199811000-00014
|View full text |Cite
|
Sign up to set email alerts
|

Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication

Abstract: Taken together, these in vivo and in vitro findings support a model whereby HIV encephalitis is sustained by virus replication in microglial cells, a process amplified by recruitment of mononuclear cells via HIV-induced MCP-1.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

10
155
3
1

Year Published

1999
1999
2014
2014

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 237 publications
(169 citation statements)
references
References 21 publications
10
155
3
1
Order By: Relevance
“…The secretion of both chemokines is up-regulated after in vitro HIV infection of primary PBMCs and MDM (56,81) or after IL-6 stimulation of MDM and promonocytic U1 and U937 cells (15). In vivo, increased levels of CXCL8/IL-8 were observed in the lymphoid tissues of HIV ϩ individuals (16), whereas high levels of CCL2/MCP-1 were observed in the cerebrospinal fluid of AIDS patients with either CMV-or HIV-associated encephalitis (58,82). Both chemokines were shown to up-regulate HIV replication in primary PBMC and MDM infected in vitro (16,57) as Only the E-86 plasmid showed superior baseline levels as well as responsiveness to IL-6 and inhibition by PTX-B.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The secretion of both chemokines is up-regulated after in vitro HIV infection of primary PBMCs and MDM (56,81) or after IL-6 stimulation of MDM and promonocytic U1 and U937 cells (15). In vivo, increased levels of CXCL8/IL-8 were observed in the lymphoid tissues of HIV ϩ individuals (16), whereas high levels of CCL2/MCP-1 were observed in the cerebrospinal fluid of AIDS patients with either CMV-or HIV-associated encephalitis (58,82). Both chemokines were shown to up-regulate HIV replication in primary PBMC and MDM infected in vitro (16,57) as Only the E-86 plasmid showed superior baseline levels as well as responsiveness to IL-6 and inhibition by PTX-B.…”
Section: Discussionmentioning
confidence: 99%
“…7A). To correlate this strong inhibitory effect to that of other cellular genes, we investigated PTX-B's capacity to interfere with chemokines such as CXCL8/IL-8 and CCL2/MCP-1, which are transcriptionally regulated by AP-1 (53,54) and can up-regulate HIV replication both in vitro (16,(55)(56)(57) and in vivo (58). Neither chemokine was detectable in the culture supernatants of either unstimulated or PTX-B-stimulated U1 (data not shown) and U1-CR1 (Fig.…”
Section: Ptx-b Prevents Hiv Production and Cxcl8/il-8 And Ccl2/ Mcp-1mentioning
confidence: 99%
“…In humans and other vertebrate animals, activated T cells that infiltrate the CNS during encephalitic DNA or RNA viral infections up-regulate expression of the chemokine receptors CCR1, CCR2, CCR5, and CXCR3 and their chemokine ligands CCL2 (CCR2), CCL3 (CCR1, CCR5), CCL4 (CCR5), CCL5 (CCR1, CCR5), and CXCL9 -CXCL11 (CXCR3) (15)(16)(17)(18)(19)(20)(21)(22)(23)(24). Although targeted deletion of CXCR3 or CXCL10 is associated with a reduction in infiltrating mononuclear cells and enhanced mortality from infection of the CNS with mouse hepatitis virus (MHV) 3 (25,26), few studies have examined regional differences in the expression of chemokine ligands during viral encephalitis.…”
Section: T He Infiltration Of Virus-specific Cd8 T Cells Is Essentialmentioning
confidence: 99%
“…However, a significant upregulation or dysregulation of CNS expression of CCL2 occurs in a variety of acute and chronic neuroinflammatory and neurodegenerative CNS disorders, implicating a role for CCL2 in pathological conditions. For example, CCL2 levels in the CNS are elevated in brain injury (Little et al, 2006), cerebral ischemia (Che et al, 2001;Minami et al, 2006), multiple sclerosis (Mahad and Ransohoff, 2003;McManus et al, 1998), human immunodeficiency virus (HIV)-associated dementia (Cinque et al, 1998) and Alzheimer's disease (Galimberti et al, 2006). Both neurotoxic and neuroprotective roles for CCL2 have been proposed in these conditions.…”
Section: Introductionmentioning
confidence: 99%